Nowadays using medicines in our daily life became a must. Humanity is calling to meet the growing need to tackle diseases every day. So companies such as pfizer are called upon to face this challenge. Pfizer is one of the world’s premier biopharmaceutical companies.
Pfizer is listed in the NYSE(PFE) with a 265$B Market cap and almost 78.000 employees.
As everybody knows very well these days, cancer is among the leading causes of death worldwide. There will be an estimated 23.6 million new cases of cancer each year by 2030 worldwide. In the United States estimated cost of cancer care by 2020 is 172.8 billion USD.
Recently, James Allison and Tasuku Honjo who pioneered an entirely new way to treat cancer have won the 2018 Nobel Prize in Physiology or Medicine. The pair showed how proteins receptors CTLA-4 on immune cells can be used to manipulate the immune system so that it attacks cancer cells. The therapy won the 2018 Nobel Prize, the culmination of nearly 25 years of research.
Health-care stocks have emerged as market leaders in the third quarter, helping push major U.S. indexes to new highs. Hedge funds and money managers have been building up positions in health-care stocks as a safety play for an eventual slowdown. The sector’s rally has been broad, with shares of pharmaceutical giants like Merck & Co. and Pfizer Inc.
Pfizer Inc.’s (PFE) stock has been on a tear reaching prices not seen in 18 years. But after soaring by 24% in 2018, the stock still may have even higher to climb, based on technical analysis, by as much as another 8%.
Pfizer now is at the 45.28$ and the target price from Jefferies is at 74$. Be part of this success ride with Pfizer and take advantage of a great rebellion in the health care sector. Till the 74$ you can grab a 64% profit, just follow us!